V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250010927 | 250008126 | null | null | Disease modification (D) | 2018-05-28 | 2018-10-21 | ETOPOSIDE | 2 | N | 250001684 | GEMCARBO |
| 250010928 | 250008126 | 1.71 | null | null | 2017-04-29 | 2017-05-03 | Bevacizumab 7.5mg/kg | 02 | N | 250001684 | GEMCARBO |
| 250010929 | 250008128 | null | null | Disease modification (D) | 2018-08-14 | 2018-08-18 | Busulfan Oral | 02 | N | 250002158 | IPM |
| 250010930 | 250011028 | 1.62 | 52.6 | Disease modification (D) | 2015-03-29 | 2015-04-19 | BENDAMUSTINE + RITUXIMAB | N | N | 250002205 | IPM |
| 250010931 | 250008129 | 1.79 | 67.7 | Curative (C) | 2017-06-25 | 2018-08-17 | Carboplatin + Vinorelbine IV | N | N | 250002469 | CARBOPLATIN |
| 250010932 | 250008132 | 1.59 | 66.5 | Palliative (P) | 2015-08-09 | 2015-11-15 | GEMCARBO | N | N | 250002533 | CARBOPLATIN |
| 250010933 | 250008134 | 1.72 | 67.4 | Palliative (P) | 2018-08-18 | 2018-08-18 | null | 2 | N | 250002551 | BORTEZOMIB |
| 250010934 | 250008135 | 1.69 | 95.3 | Disease modification (D) | 2015-02-05 | 2015-02-05 | Dasatinib | 2 | N | 250002579 | PEMBROLIZUMAB |
| 250010935 | 250008136 | 1.75 | null | Palliative (P) | 2017-07-07 | 2017-07-07 | Enzalutamide | 02 | N | 250002579 | DA |
| 250010936 | 250008136 | 1.63 | 71 | Palliative (P) | 2018-09-26 | 2018-09-30 | Pemetrexed | Y | N | 250002579 | GEMCARBO |
| 250010937 | 250008137 | 1.61 | 48.7 | Disease modification (D) | 2016-11-21 | 2016-11-23 | IPM | N | null | 250003100 | IPM |
| 250010938 | 250008138 | 1.7 | 66.3 | Palliative (P) | 2014-09-15 | 2016-09-08 | Carboplatin + Paclitaxel (3 weekly) | N | N | 250003100 | CARBOPLATIN |
| 250010939 | 250008139 | 1.72 | 143 | Curative (C) | 2016-12-26 | 2016-12-26 | IPM | null | N | 250003404 | PAZOPANIB |
| 250010940 | 250008139 | null | 80 | Palliative (P) | 2016-04-30 | 2018-03-04 | AML18 PILOT TRIAL | Y | null | 250003404 | GEMCARBO |
| 250010941 | 250008141 | null | 57.6 | Curative (C) | 2018-08-09 | 2018-08-10 | FBC Conditionining | 2 | N | 250003557 | IRINOTECAN + MDG |
| 250010942 | 250008142 | 1.54 | 69.4 | Palliative (P) | 2016-11-13 | 2016-11-13 | CARBOPLATIN + GEMCITABINE | N | N | 250003557 | CARBOPLATIN + LIPOSOMAL DOX |
| 250010943 | 250008142 | 1.79 | 45.5 | null | 2016-12-20 | 2016-12-30 | Epirubicin (weekly) | N | null | 250003557 | PEMETREXED |
| 250010944 | 250008143 | 1.63 | 52 | Curative (C) | 2018-06-22 | 2018-06-23 | Cytarabine Low Dose | 2 | N | 250004027 | CARBOPLATIN + DOXORUBICIN |
| 250010945 | 250008144 | null | 58.25 | Disease modification (D) | 2018-11-20 | 2018-11-20 | GemCarbo Days 1+8 | 2 | N | 250004229 | COMMAND TRIAL |
| 250010946 | 250008145 | 1.75 | 79 | Curative (C) | null | 2013-04-22 | NHL 2003 Gp B COP | 2 | N | 250004229 | AZACITIDINE |
| 250010947 | 250008145 | 0 | 74 | null | null | 2017-01-20 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 250004229 | CARBOPLATIN + DOXORUBICIN |
| 250010948 | 250008148 | 1.6 | 69 | Curative (C) | 2016-02-20 | 2016-02-20 | Busulfan Oral | N | N | 250004688 | GEMCARBO |
| 250010949 | 250008148 | 0 | 74 | null | 2018-01-31 | 2018-01-31 | Azacitidine | 02 | N | 250004688 | GEMCARBO |
| 250010950 | 250008148 | 1.53 | null | Disease modification (D) | 2018-11-19 | 2019-09-03 | Cytarabine High Dose | 02 | N | 250004688 | CARBOPLATIN |
| 250010951 | 250008149 | null | 60.8 | Palliative (P) | 2017-07-15 | 2017-07-22 | COMMAND trial | N | Y | 250004861 | BORTEZOMIB |
| 250010952 | 250008151 | 1.8 | 62.5 | Palliative (P) | 2015-09-25 | 2015-10-06 | GEMCARBO | 02 | N | 250005040 | CARBOPLATIN + PACLITAXEL |
| 250010953 | 250008151 | 1.78 | 0 | Palliative (P) | null | 2014-11-24 | IPM | N | N | 250005040 | AZACITIDINE |
| 250010954 | 250008153 | null | null | Curative (C) | 2019-03-25 | 2019-03-25 | Pemetrexed | 01 | N | 250005122 | BEVACIZUMAB |
| 250010955 | 250008154 | 1.68 | 104 | Palliative (P) | 2014-05-17 | 2014-05-17 | Venetoclax | N | N | 250005144 | PEMETREXED |
| 250010956 | 250008155 | null | null | Palliative (P) | null | 2018-01-11 | VEPEMB | N | N | 250005192 | CARBOPLATIN |
| 250010957 | 250008157 | null | 83.7 | Disease modification (D) | 2016-01-04 | 2016-01-16 | R GCVP | N | null | 250005536 | GEMCITABINE |
| 250010958 | 250008158 | 1.72 | 71 | Palliative (P) | null | 2016-08-04 | CARBOPLATIN + GEMCITABINE | N | N | 250005580 | GEMCITABINE |
| 250010959 | 250011041 | 1.51 | null | Disease modification (D) | 2018-02-19 | 2018-02-19 | R GCVP | Y | N | 250005596 | CARBOPLATIN + VINORELBINE |
| 250010960 | 250008162 | 1.61 | 93 | Palliative (P) | 2013-11-30 | 2013-11-30 | CARBOPLATIN + PACLITAXEL | N | N | 250005623 | GEMCARBO |
| 250010961 | 250008163 | 1.73 | 95.5 | null | 2017-02-03 | 2017-11-24 | IPM | N | N | 250005674 | GEMCARBO |
| 250010962 | 250008165 | 1.59 | 0 | Adjuvant (A) | 2019-03-21 | 2019-03-22 | IPM | 02 | N | 250005935 | PEMETREXED |
| 250010963 | 250008165 | 1.48 | 0 | Curative (C) | 2018-08-19 | 2018-10-01 | BUSULFAN | N | N | 250005935 | GEMCARBO |
| 250010964 | 250012179 | null | 57.6 | Disease modification (D) | 2016-04-12 | 2016-04-12 | GEMCARBO | N | N | 250006185 | CARBOPLATIN + PACLITAXEL |
| 250010965 | 250008167 | null | 66 | Curative (C) | 2016-01-30 | 2016-01-30 | Venetoclax | N | N | 250006185 | GEMCARBO |
| 250010966 | 250008169 | 1.84 | 60.9 | Disease modification (D) | 2017-10-03 | 2017-10-25 | GEMCARBO | 02 | null | 250006428 | GDP |
| 250010967 | 250008169 | 1.67 | 74.4 | Curative (C) | 2018-12-08 | 2018-12-08 | IPM | 2 | N | 250006428 | AZACITIDINE |
| 250010968 | 250008170 | 0 | 124.3 | Disease modification (D) | 2016-09-04 | 2016-09-04 | TCX | 02 | N | 250006926 | IPM |
| 250010969 | 250011046 | null | null | Palliative (P) | 2018-06-26 | 2018-07-01 | Bevacizumab | N | N | 250007030 | CARBOPLATIN + PACLITAXEL |
| 250010970 | 250011046 | 1.57 | 72 | Palliative (P) | 2016-11-17 | 2016-11-17 | Eribulin | Y | N | 250007030 | RITUXIMAB |
| 250010971 | 250008171 | 1.72 | 78.3 | Palliative (P) | 2015-07-30 | 2015-06-30 | Oxaliplatin + Modified de Gramont | N | N | 250007291 | OXALIPLATIN + MDG |
| 250010972 | 250008173 | 0 | null | Curative (C) | 2014-10-20 | 2014-10-20 | GemCarbo Days 1+8 | N | N | 250007291 | MITOXANTRONE |
| 250010973 | 250008174 | 1.65 | 76.8 | Adjuvant (A) | 2019-04-11 | 2019-04-13 | GEMCARBO | N | N | 250007536 | ENZALUTAMIDE |
| 250010974 | 250008175 | 1.73 | 88.4 | Palliative (P) | 2018-10-05 | 2018-10-05 | Carboplatin + Vinorelbine Oral | N | N | 250007628 | PEMBROLIZUMAB |
| 250010975 | 250008176 | null | 67.95 | Palliative (P) | 2014-03-14 | 2014-03-21 | GemCarbo Days 1+8 | 99 | N | 250007681 | IPM |
| 250010976 | 250008177 | 1.69 | 68 | Curative (C) | 2017-07-12 | 2017-07-19 | BUSULFAN | N | N | 250007949 | GEMCARBO |